Latest news about Achyut Healthcare
Achyut Healthcare
5.06
+0.16(+3.27%)
Company Performance:
View Company Insights1D+3.27%
1M-8.66%
6M-10.28%
1Y+48.82%
5Y+400.99%
More news about Achyut Healthcare
12Mar 26
Achyut Healthcare Limited Receives BSE In-Principle Approval for Preferential Issue of 58,00,000 Equity Shares
Achyut Healthcare Limited has obtained BSE in-principle approval for preferential allotment of 58,00,000 equity shares of Re.1/- each at minimum ₹5 per share to promoters and non-promoters. The approval, granted under SEBI LODR Regulations, requires strict compliance with multiple regulatory frameworks and mandates specific internal controls. The company must apply for listing within twenty days of allotment and fulfill comprehensive post-issue formalities.
21Jan 26
Achyut Healthcare Reports Q3FY26 Results, Announces ₹3.48 Crore Preferential Issue and Capital Expansion Plans
Achyut Healthcare Limited reported Q3FY26 results with total income of ₹161.12 lakhs and net profit of ₹0.43 lakhs for the quarter ended December 31, 2025. The Board approved a preferential issue of 58 lakh equity shares worth ₹3.48 crores at ₹6 per share, increased authorized capital from ₹24 crores to ₹26 crores, and relocated the registered office within Ahmedabad. An EGM is scheduled for February 19, 2026, to seek shareholder approval for these initiatives.
02Jan 26
Achyut Healthcare Gets BSE Approval to Migrate from SME to Main Board Platform
Achyut Healthcare Limited has successfully obtained BSE approval to migrate its equity shares from the SME platform to the Main Board Platform, with trading set to begin on January 02, 2026. The Small Cap pharmaceutical company, with a market cap of ₹133.80 crores, has completed all regulatory requirements for this significant corporate milestone that enhances investor accessibility.
26Dec 25
Akshit Raychahuf Increases Achyut Healthcare Stake to 1.52% via Open Market
Promoter Akshit M. Raychahuf has systematically increased his shareholding in Achyut Healthcare Limited through multiple open market transactions conducted between November and December. Starting with acquisitions of 31,500 shares each on November 17 and 18, he raised his stake from 1.49% to 1.52%, followed by additional purchases in December that brought his total ownership to 1.92%.
07Nov 25
Akshit M. Raychahuf Boosts Stake in Achyut Healthcare Limited
Akshit M. Raychahuf, a promoter of Achyut Healthcare Limited, has increased his stake in the company through open market transactions. He acquired 94,500 shares, raising his shareholding from 31,21,020 shares (1.32%) to 32,15,520 shares (1.37%). The transaction was disclosed in compliance with SEBI regulations.
06Nov 25
Promoter Akshit M. Raychahuf Boosts Stake in Achyut Healthcare Limited
Akshit M. Raychahuf, a promoter of Achyut Healthcare Limited, has acquired 94,500 shares (0.04% of total share capital) through open market transactions on November 4, 2025. This increased his shareholding from 30,26,520 (1.28%) to 31,21,020 (1.32%) shares. The company's total equity share capital stands at Rs. 23,55,57,000, comprising 23,55,57,000 shares with a face value of Re. 1 each.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Dr Reddys Laboratories
Lupin
Mankind Pharma
Zydus Life Science
Aurobindo Pharma
Laurus Labs
1,878.20
(+0.81%)
6,760.50
(-2.33%)
4,405.70
(+0.04%)
1,432.10
(-0.32%)
1,336.70
(+2.54%)
2,276.20
(+0.80%)
2,503.00
(+1.66%)
1,011.70
(+2.02%)
1,511.80
(+0.06%)
1,323.60
(+0.62%)
Get More Market Insights with
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
